Paraoxonase 1 (PON1) modulates the toxicity of mixed organophosphorus compounds
- Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98195 (United States)
- Department of Medicine (Div. of Medical Genetics), University of Washington, Seattle, WA 98195 (United States)
A transgenic mouse model of the human hPON1{sub Q192R} polymorphism was used to address the role of paraoxonase (PON1) in modulating toxicity associated with exposure to mixtures of organophosphorus (OP) compounds. Chlorpyrifos oxon (CPO), diazoxon (DZO), and paraoxon (PO) are potent inhibitors of carboxylesterases (CaE). We hypothesized that a prior exposure to these OPs would increase sensitivity to malaoxon (MO), a CaE substrate, and the degree of the effect would vary among PON1 genotypes if the OP was a physiologically significant PON1 substrate in vivo. CPO and DZO are detoxified by PON1. For CPO hydrolysis, hPON1{sub R192} has a higher catalytic efficiency than hPON1{sub Q192}. For DZO hydrolysis, the two alloforms have nearly equal catalytic efficiencies. For PO hydrolysis, the catalytic efficiency of PON1 is too low to be physiologically relevant. When wild-type mice were exposed dermally to CPO, DZO, or PO followed 4-h later by increasing doses of MO, toxicity was increased compared to mice receiving MO alone, presumably due to CaE inhibition. Potentiation of MO toxicity by CPO and DZO was greater in PON1{sup -/-} mice, which have greatly reduced capacity to detoxify CPO or DZO. Potentiation by CPO was more pronounced in hPON1{sub Q192} mice than in hPON1{sub R192} mice due to the decreased efficiency of hPON1{sub Q192} for detoxifying CPO. Potentiation by DZO was similar in hPON1{sub Q192} and hPON1{sub R192} mice, which are equally efficient at hydrolyzing DZO. Potentiation by PO was equivalent among all four genotypes. These results indicate that PON1 status can have a major influence on CaE-mediated detoxication of OP compounds.
- OSTI ID:
- 21272527
- Journal Information:
- Toxicology and Applied Pharmacology, Vol. 236, Issue 2; Other Information: DOI: 10.1016/j.taap.2009.02.001; PII: S0041-008X(09)00057-X; Copyright (c) 2009 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0041-008X
- Country of Publication:
- United States
- Language:
- English
Similar Records
Toxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism
Paraoxonase 1 (PON1) Status and Risk of Insecticide Exposure